Bioscience Americas Presents at Venture Capital Event

Share Article

Bioscience Americas was among a select group of emerging growth companies invited to participate at a recent GoDaddy sponsored venture capital investment forum.

Bioscience Americas, LLC, a leading international developer of for-profit autologous stem cell wellness centers, is pleased to report than they were among a select group of companies invited to participate in the GoDaddy sponsored Funding Post Venture Capital and Angel Network Investor Roundtable held recently at GoDaddy’s headquarters in Scottsdale, Arizona.

Bioscience Americas is the international development partner of the Global Institute of Stem Cell Therapy and Research. Based in San Diego, California at the University of California Medical Center, the Global Institute is a worldwide consortium of stem cell scientists and biotechnology researchers devoted to finding cures to autoimmune diseases such as Multiple Sclerosis, Lou Gehrig’s Disease, and Diabetes among others. Bioscience Americas and the Global Institute are working together to develop medical wellness centers in South America employing FDA approved adult stem cell technology.

This periodic event is held at select locations throughout the country and is attended by major venture capital investors and hedge funds seeking to partner with emerging growth companies.

The presentation was made by Bioscience Americas Executive Vice President Steve Miller with CEO Eric Stoffers and President Bill Deegan in attendance to answer investor questions.

Mr. Stoffers indicated that he was pleased that the company had the opportunity to participate in the event. “We are seeing tremendous interest in the Bioscience Americas business model. Autologous stem cell therapies represent a major paradigm shift in patient care and treatment. Our mission is to work with the Global Institute to bring the science out of the lab and into the marketplace. We’re grateful for the opportunity we had to meet with many important members of the institutional investment community and are expecting positive results from our participation in the forum”.

This sentiment was echoed by Mr. Deegan who noted that the company anticipated participating in additional venture capital events throughout the country over the next few months.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bill Deegan
Visit website